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Abstract : This review aims at defining the link between
physiological sleep and general anesthesia. Despite com-
mon behavioral and electrophysiological characteristics
between both states, current literature suggests that the
transition process between waking and sleep or anesthe-
sia-induced alteration of consciousness is not driven by
the same sequence of events. On the one hand, sleep
originates in sub-cortical structures with subsequent
repercussions on thalamo-cortical interactions and
 cortical activity. On the other hand, anesthesia seems to
primarily affect the cortex with subsequent repercussions
on the activity of sub-cortical networks. This discrepan-
cy has yet to be confirmed by further functional brain
imaging and electrophysiological experiments. The rela-
tionship between the observed functional modifications
of brain activity during anesthesia and the known bio-
chemical targets of hypnotic anesthetic agents also
remains to be determined. 
Key words : Sleep ; general anesthesia ; consciousness ;
mechanisms.
INTRODUCTION
When referring to induction of general anes-
thesia, vernacular language often uses the expres-
sion of “putting someone to sleep”. This is related
to the behavioral characteristics commonly thought
to be part of both states, including altered con-
sciousness, reduced movements, and closing of the
eyes (1). Besides behavioral similarities, sleep and
anesthesia share common electroencephalographic
modifications including slow wave activity (2).
Hence, temptation of merging sleep and anesthesia
mechanisms into a hodgepodge is high. In order to
understand how hypnotic anesthetic agents produce
an alteration of consciousness, three main types of
experimental paradigms have been used. In vitro
electrophysiological studies on neurons and brain
tissues have allowed identifying their biochemical
targets, mainly in terms of neurotransmitter sys-
tems, and ionic channels. Animal models, and the
study of mutants, have confirmed the involvement
of specific neurotransmitter systems, and shed light
on the influence of hypnotic agents on sub-cortical
arousal systems. Finally, electrophysiological and
imaging studies in humans have evidenced their
selectivity on specific functional regions and net-
works in the brain. The current challenge consists in
making the link between all those mechanistic
 elements, compare them to the known mechanisms
of sleep, synthesize the similarities and differences,
and try to determine if the initiation of the cascade
leading to the alteration of consciousness during
sleep and anesthesia is located at the same place in
the brain and involves the same brain mechanisms.
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This will be the aim of the present review. After
comparing the behavioral and electrophysiological
characteristics of sleep and anesthesia, the systems
sustaining arousal and the emergence of conscious-
ness will be described. The known mechanisms of
physiological sleep will then be summarized. This
will allow placing hypnotic anesthetic agents with-
in those systems and mechanisms by envisaging
their multiple biochemical targets, their action on
sleep and arousal pathways, and, finally, their
 functional effect on the brain.
BEHAVIORAL AND ELECTROENCEPHALOGRAPHIC CHARAC-
TERISTICS OF SLEEP AND GENERAL ANESTHESIA
The behavioral resemblance between sleep
and general anesthesia does not outlive detailed
analysis. According to Franks and Zecharia, sleep
can be defined as “a naturally occurring, periodic
state of rest during which consciousness of one’s
environment and responses to external stimuli are
largely suspended” (1). However, resting attitude,
altered environmental awareness, and suppression
of responses to external stimuli are not the only
behavioral elements that must be part of the
description of sleep, and of other altered conscious-
ness states. A more precise description should
include the presence or absence of wakefulness,
spontaneous or evoked purposeful movements,
muscle tone, awareness of the environment,
response to command, self perception, mental
imagery, and reversibility upon external stimulation
(Table 1).
Physiological sleep is not a unitary entity. One
must discriminate the so called rapid-eye-
 movement (REM) sleep from the slow wave sleep
(or non-REM sleep). During non-REM sleep, of
course, wakefulness is absent, and the eyes are
closed. Muscle tone is normal, and spontaneous
movements occur. This state is associated with
 various degrees of consciousness alteration, whose
reversibility by external stimulation depends on
sleep depth. Awareness of the environment and
 ability to respond to command fall off. There is no
awareness of self and mental imagery, despite
 possible occurrence of dream. REM sleep is more
frequently associated with dreaming, and hence
mental imagery, with virtual self perception. Due to
muscle atonia, no movements occur, except for
 specific movements of the eyes. Awareness of the
environment is altered, as well as response to
 command. REM sleep is easily reversed by external
stimulation. Surface electroencephalographic
Table 1
Behavioral and surface electroencephalogram (EEG) characteristics of sleep and general anesthesia. n-REM = non-rapid-eye-
movement ; REM = rapid-eye-movement ; Inhib. neurotrans. = agents that promote inhibitory neurotransmission such as
barbiturates, propofol, benzodiazepines, etomidate, and halogenated vapors ; α2 agonists = α2-adrenergic agonists ;
St.-dep. = stage-dependent ; Des. fast = desynchronized fast activity
Sleep General anesthesia
n-REM REM Inhib. neurotrans. Ketamine Xenon α2 agonists
Wakefulness Absent Absent Absent Present Absent Reduced
Movements
Spontaneous Present Absent Absent Present Absent Reduced
Evoked Present Absent Absent Absent Absent Reduced
Purposeful Present Absent Absent Absent Absent Reduced
Muscle tone Normal Atonia Reduced Normal Few effects Normal
Environment awareness Absent Absent Absent Absent Absent Reduced
Response to command Absent Absent Absent Absent Absent Altered
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(EEG) modifications during non-REM sleep
include waxing and waning oscillations of 12-
15 Hz frequency lasting for at least a half second
(spindle oscillations) and K-complexes (high volt-
age negative peak immediately followed by a slow-
er positive complex) at sleep onset, and widespread
increased power in lower frequencies (delta waves
or slow oscillations, 0.5-4 Hz) (2) at deeper stages.
Slow oscillations originate in frontal regions and
propagate to posterior regions of the cortex follow-
ing a reproducible track (3). REM sleep displays
EEG patterns that are close, but not identical, to
those observed during the wake state, including low
voltage desynchronized fast activity, and increased
power in the theta range (4-10 Hz) (4, 5). 
During general anesthesia, alteration of con-
sciousness is achieved using anesthetic agents with
hypnotic properties. All of them do not alter the
above-cited behavioral elements in the same way.
In that respect, different classes must be distin-
guished. Agents that mainly enhance inhibitory
neurotransmission such as barbiturates, propofol,
benzodiazepines, etomidate, and halogenated
vapors suppress wakefulness, awareness of the
environment and response to command, as well as
self awareness. They also lessen muscle tone, and
movements. When maintained at sufficiently high
concentrations, reversibility by external stimulation
is difficult.  Hence, those agents produce a state that
is rather close to deep non-REM sleep, with the
exceptions of reduced muscle tone and movements,
and less easy reversibility. However, dreaming has
been reported during propofol and desflurane anes-
thesia (6), particularly during emergence from
anesthesia. In case of dreaming, electroencephalo-
graphic activity is similar to that observed during
REM sleep. Otherwise, surface EEG alterations
achieved with those agents depend on the adminis-
tered dose. When increasing doses, beta activation
first occurs (low amplitude 13-30 Hz waves),
 followed by a progressive slowing towards delta
activity, near burst suppression (bursts followed by
periods of flat signal), and, eventually, isoelectrici-
ty (7). Spindles can be observed (6), and slow wave
activity appears similar to slow waves of non-REM
sleep with subtle differences (2).
Ketamine is certainly the most representative
among the hypnotic agents that mainly act through
an inhibition of excitatory neurotransmission.
Nitrous oxide can also be considered as part of that
class. These agents have long been qualified as
“dissociative” (8), insofar as they produce uncon-
sciousness while preserving wakefulness, a state
close to the recently renamed vegetative state, or
Unresponsive Wakefulness Syndrome (UWS) (9).
During ketamine administration, spontaneous
 reptilian non purposeful movements are commonly
present. Subjects loose awareness of their environ-
ment and response to command. Intense dreamlike
experience often occurs, with inadequate self
 perception. Reversibility upon external stimulation
is not obtainable at high doses. Regarding surface
EEG, ketamine produces an increase in high
 amplitude rhythmic theta activity, reduced alpha
activity (8-13 Hz), and polymorphic delta activity
with scattered beta activity (10).
Alpha2-adrenergic agonists and inert gases also
have hypnotic properties but do not belong to the
above-mentioned classes. The decreased alertness
and the state of tranquility induced by α2-adrenergic
agonists such as dexmedetomidine or clonidine are
easily reversed by external vocal or tactile stimula-
tion. With increasing concentration of such agents,
subjects long keep the ability to respond to verbal
command, and several cognitive brain functions are
preserved, although memory and motor skill
impairment has been reported (11, 12). Hence,
α2-adrenergic agonists are remarkable in that they
alter wakefulness while preserving several aspects
of awareness. The associated EEG changes are
characterized by an increased energy in the lower
frequency band (delta and theta activity) and in the
spindle frequency range (12-15 Hz) (1, 13).
Therefore, α2-adrenergic agonist sedation is behav-
iorally and electrophysiologically very close to
non-REM sleep. Xenon is currently the only inert
gas used in clinical practice. Although having dif-
ferent biochemical targets, its behavioral effects
mimic those of halogenated vapors (14), as well as
their effects on the electroencephalogram (10).
In light of the above descriptions, sleep and
anesthesia-induced behavioral and electroencephalo-
gram modifications are heterogeneous. Hence, it is
necessary to describe the mechanisms known to
sustain arousal and awareness, before deeply inven-
torying the mechanisms of each state and find the
link between them.
AROUSAL PATHWAYS
Cortical arousal and wakefulness during nor-
mal waking is sustained by a complex network of
interconnected nuclei, with reciprocal projections
to the cortex. Those neural pathways can be divid-
ed into three categories, depending on the location
of their nuclei of origin, namely the pons, the mid-
brain, and the hypothalamus-basal forebrain
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(Table 2). A detailed description of each nucleus
and its projections can be found in the excellent
review by Franks (15).
Pontine nuclei are cholinergic, noradrenergic,
serotonergic, or glutamatergic. Cholinergic pontine
nuclei project onto pontine, thalamic, mesencephal-
ic reticular formation, and basal forebrain arousal
nuclei, as well as onto regions of the prefrontal
 cortex. The locus coeruleus is the pontine source of
noradrenergic neurons. It has a direct arousal effect
on the cortex, and indirect effects through thalamic
innervations and the inhibition of sleep-promoting
pathways in the basal forebrain and preoptic areas.
Pontine serotonergic neurons originate in the dorsal
raphe and project onto the cortex, thalamus, and
basal forebrain, while pontine glutamatergic
 neurons emerge from the oral pontine nucleus and
project onto the thalamus and the cortex.
Arousal nuclei of the midbrain are gluta -
matergic and dopaminergic. Glutamatergic neurons
project onto thalamic, basal forebrain, and pontine
arousal nuclei, as well as onto the locus coeruleus.
Dopaminergic neurons innervate the thalamus, the
basal forebrain, and the cortex.
In the hypothalamus, orexinergic and hista-
minergic nuclei project diffusely to the cortex, thal-
amus, and other arousal nuclei. The cholinergic
sources of the basal forebrain spread onto the cor-
tex, the limbic system, and specific thalamic arous-
al nuclei.
From this schematic summary of the complex
arousal network, it appears that acetylcholine, nora-
drenaline, serotonin, histamine, orexin, glutamate
and dopamine are the main neurotransmitters of
wakefulness, and that all of them can have direct
arousal effects on the cortex. They endorse cortical
Table 2
Schematic summary of arousal systems. + = arousal promoting effect ; – = inhibition ; LC = locus coeruleus
Location of nuclei Neurotransmitter Projections
Pons Acetylcholine + Prefrontal cortex




Noradrenaline (LC) + Cortex
+ Arousal nuclei Thalamus




+ Arousal nuclei Thalamus
Basal forebrain





+ Arousal nuclei Thalamus
Basal forebrain
Hypothalamus Orexin + Diffuse Arousal nuclei
Thalamus
Cortex
Histamin + Diffuse Arousal nuclei
Thalamus
Cortex
Basal forebrain Acetylcholine + Cortex
+ Limbic system
+ Thalamus
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arousal, which is a prerequisite for the emergence
of consciousness and its several components.
EMERGENCE OF CONSCIOUSNESS
The conscious experience originates in the
cerebral cortex. Two main theories are currently
proposed to explain the emergence of mental con-
tent. The first one is the global workspace theory
(16, 17). According to this theory, specialized func-
tional brain networks made of hierarchically organ-
ized interconnected brain regions synchronize their
activity to generate perceptual and mnemonic infor-
mation. Interconnections between brain regions
dynamically change according to circumstances.
The generated information is pooled into a global
workspace, and regulating systems allow one
 cognitive element or the other to separate from
background information and emerge into the con-
scious field. The second theory is the information
integration theory of consciousness (18), which has
received more support from experimental evidence
than the first one. In this theory, information would
be generated by stereotypical patterns of brain
responses, and integration of information would
emerge from connectivity inside large scale cere-
bral networks. Some of those networks are qualified
as resting state networks, or ‘intrinsic connectivity
networks’ (19), because they elicit functional con-
nectivity in a lying down individual with eyes
closed, no external stimulation, and doing nothing
else but thinking. Among the resting state networks,
the medial frontoparietal default mode network
(DMN) is involved in the awareness of self (20),
and the dorsolateral frontoparietal executive control
network (ECN) is involved in the awareness of the
environment (21) (Fig. 1). Resting state auditory
and visual networks have also been described (22).
DMN and ECN have anti-correlated activities, that
is alternate activation approximately every 20 sec-
onds (21, 23). Conscious perception of external
stimulation would only be possible during ECN
activation. Peripheral sensory information would
first reach the sensory networks through the
 thalamus and under the control of sub-cortical
 thalamo-regulatory systems involving the puta-
men (24). It would then pass through several
 hierarchically organized levels of integration,
including cross-modal interaction. Other compo-
nents of consciousness would be sustained by
 specific networks, such as the one for associative
learning (25), emotions (26), or pain and its
 emotional components (27).
CHANGES ASSOCIATED WITH SLEEP
Inhibitory nuclei that are active during sleep
are mainly γ-amino-butyric acid(GABA)ergic and
galaninergic. They are located in the preoptic area
and basal forebrain. Their firing rate increases
immediately prior to sleep. Among them, the ven-
tro-lateral preoptic nucleus (VLPO) appears to play
a key role (28). In the waking subject, the noradren-
ergic locus coeruleus tonically inhibits the VLPO.
At sleep onset, this inhibition disappears, and the
VLPO releases the inhibitory neurotransmitter
GABA at several sites, including the histaminergic
tuberomamillary nucleus (TMN), and all the nora-
drenergic, serotonergic, cholinergic, and orexiner-
gic arousal nuclei described above. The widespread
inhibition of arousal pathways switches tightly
interconnected thalamic and cortical neurons from a
tonic firing to a hyperpolarized and burst firing
mode (1). As a consequence, thalamic oscillations
occur, leading to the emergence of sleep spindles in
the EEG. Diffuse synchronization of thalamic and
cortical activity also occurs, resulting in the out-
break of slow delta waves. Functional brain imag-
ing has revealed that global brain activity decreases
during non-REM sleep, with marked relative
decreases in selected brain regions including brain-
stem, thalamus, basal ganglia, and basal forebrain,
as well as in the prefrontal cortex, anterior cingulate
cortex, and precuneus (5). However, specific sub-
cortical and cortical regions involved in the genera-
tion of spindles and slow waves increase their rela-
tive activity (5). Functional connectivity within the
DMN is impaired during deep non-REM sleep (29),
but not during light non-REM sleep (30).
Perception and interpretation of external informa-
tion, although still possible, is altered. It seems that,
beside a possible guardian role of the prefrontal
cortex in assessing saliency of incoming informa-
tion and triggering an awakening response if neces-
sary, there exists a sleep-induced deactivation of
primary sensory areas (5).
The initiation of REM sleep depends on com-
plex feed-back interactions between cholinergic
REM sleep promoting neurons located in the
tegmentum, and serotonergic, noradrenergic, and
GABAergic REM sleep inhibiting neurons located
in the dorsal raphe, locus coeruleus, and reticular
formation (31). These interactions would lead to
cyclic occurrences of REM sleep behavioral and
EEG patterns, including muscle atonia, rapid-eye
movements, and EEG disynchronization.
Regarding global brain activity, no significant dif-
ference from wakefulness can be found, although
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several brain regions increase their relative activity
(e.g. tegmentum, thalamus, basal forebrain, amyg-
dala, hippocampus, anterior cingulate cortex, and
temporo-occipital areas), while others decrease it
(dorsolateral prefrontal cortex, posterior cingulate,
precuneus, and inferior parietal cortex) (5). In
 contrast to non-REM sleep, few are known about
external information processing during REM sleep.
BIOCHEMICAL TARGETS OF HYPNOTIC ANESTHETIC AGENTS
Having summarized the physiology of waking
and sleep, we can now discuss the possible targets
of hypnotic anesthetic agents within those systems.
The first level to be explored is the molecular level.
In vitro electrophysiological recordings and the
study of mutants have allowed identifying a large
number of neurotransmitter receptors, ion channels,
and other functional neuronal proteins that are sen-
sitive to the action of hypnotic anesthetic agents.
Among them, only a few have received enough
experimental support to be linked to the clinical
effect of anesthetic agents (15) (Table 3).
The first one is the type A GABA receptor,
which can be synaptic or extra-synaptic, and is
widely distributed across the brain. GABA is a
major inhibitory neurotransmitter. Agents such as
Fig. 1. — Artwork of some of the brain regions (dark) involved in two intrinsic connectivity networks sustaining consciousness. Upper
part : sagittal (A) and cranial (B) view of the brain. The medial frontoparietal default mode network (DMN) sustains the awareness of
self, and involves the mesiofrontal cortex (F), the posteromedial cortex (P, essentially the precuneus and the posterior cingulate cortex),
and the thalamus (T). Lower part : right (C) and left (D) view of the brain. The dorsolateral frontoparietal executive control network
(ECN) sustains the awareness of the environment and involves more lateral parts of the frontal and parietal cortex. Adapted from (66).
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propofol, halogenated vapors, etomidate, benzodia -
zepines, and barbiturates have been demonstrated to
promote GABAergic, and hence inhibitory neuro-
transmission (14).
Some types of potassium channels, the two-
pore potassium channels (TREK, TASK, and
TRESK channels), can be activated by hypnotic
anesthetic agents, with a net result of hyperpolariza-
tion and neuronal inhibition. This is the case for
halogenated vapors, nitrous oxide, ketamine and
xenon (32). Those potassium channels are widely
distributed across the brain, and are either pre -
synaptic or postsynaptic. They are considered to be
responsible for the background modulation of
 neuronal excitability.
Another major target of hypnotic anesthetic
agents is the N-methyl-D-aspartate (NMDA) gluta-
mate receptor subtype, whose inhibition causes
extinction of the slow components of synaptic
transmission (15). NMDA receptors are inhibited
by halogenated vapors, nitrous oxide, xenon, and
ketamine. This inhibition is mainly responsible for
their anti-noxious effect at the level of the dorsal
horn of the spinal cord, and can probably not
account alone for their hypnotic effect. The other
hypnotic agents, such as propofol, are not or only
weak inhibitors of NMDA receptors (33).
Central cholinergic neurotransmission plays
an important role in cortical arousal (34), and sever-
al hypnotic agents including propofol, barbiturates,
halogenated vapors, xenon, nitrous oxide and keta-
mine have been shown to alter nicotinic and/or
muscarinic transmission. The glycine receptor is
another potential target, mainly for halogenated
volatile anesthetics. It is frequently associated with
GABAA receptors, and mediates neuronal inhibition
(14, 15). Hyperpolarization-activated cation (HCN)
channels are important regulators of neuronal
excitability and rhythmicity (35), particularly in
thalamocortical neurons where they contribute to
modulate thalamocortical oscillations (15).
Propofol, and, to a lesser extent, halogenated vapors
inhibit those channels. Finally, presynaptic voltage-
gated sodium channels are sensitive to the effect of
halogenated volatile anesthetic agents, and their
inhibition can delay glutamatergic neurotransmis-
sion (36).
Given the extraordinary multiplicity of bio-
chemical targets, and their large distribution across
the brain, there must be subtle agent- and dose-
dependent differential tuning of the effect of hyp-
notic agents on each of them to end up with the
pharmacodynamic consequences of anesthesia.
Two options are available to understand this fine
tuning, either look at the effect of hypnotic agents
on specific sleep/arousal and consciousness net-
works using animal models, or examine the func-
tioning brain using functional brain imaging or
electrophysiological techniques.
ANESTHETIC AGENT TARGETS WITHIN AROUSAL AND SLEEP
SYSTEMS
The behavioral and electrophysiological
 similarities between sleep and anesthesia have long
prompted scientists to search for an anesthesia-
operated consciousness switch within sleep/arousal
networks (37). Indeed, there could be an enhance-
ment of sleep promoting pathways activity, an
 inhibition of arousal systems, an alteration of
 thalamo-cortical interactions, or a combination of
these mechanisms. Mutant rodents for specific
receptors, stereotaxic lesions of selected nuclei,
quantification of c-Fos protein (a marker of
 neuronal activity) expression, and brain slice or in
vivo electrophysiological recordings in animals, in
the presence of specific agonists or antagonists,
have been used to evidence the effect of hypnotic
agents on those systems. Most of these studies are
indirect arguments of such effects, and translation
to the in vivo human brain is not easy (37). In
 addition, the involved mechanisms could be
 different during induction of and emergence from
anesthesia (38, 39). Among the arousal pathways,
cholinergic, noradrenergic, serotonergic (15),
 orexinergic (40) and histaminergic (41, 42) systems
have mostly been incriminated. The inhibition of
arousal systems could be the result of a GABAergic
neurotransmission enhancement within sleep path-
ways (28, 40). Regarding the cholinergic systems,
the administration of centrally acting cholinesterase
inhibitors can reverse propofol (34) and sevoflu-
rane-induced (43) loss of consciousness in humans.
In that case, a brain activity pattern similar to the
wake state is restored (44). However, it could be
that these effects only result from a sufficiently
powerful activation of cholinergic arousal, inde-
pendently from the basal mechanisms of anesthe-
sia-induced alteration of consciousness (15). The
strongest arguments for the involvement of sleep
pathways during a pharmacologically-induced
alteration of consciousness are probably those
obtained for the α2-adrenergic agonists clonidine
and dexmedetomidine (13, 45) that inhibit the locus
coeruleus.
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FUNCTIONAL EFFECTS OF ANESTHESIA
At this stage of our review, further understand-
ing of the mechanisms of anesthesia-induced alter-
ation of consciousness can only come from whole
brain functional observations, using techniques that
have enough spatial and temporal resolution.
Among them, positron emission tomography
(PET), functional magnetic resonance imaging
(fMRI), functional near infrared spectroscopy
(fNIRS) and sophisticated electroencephalographic
studies, combined with transcranial magnetic
 stimulation (TMS), have allowed substantial
progress (46).
The first functional studies of the brain under
anesthesia demonstrated that agents such as propo-
fol (47, 48), halogenated vapors (49), barbitu-
rates (50), benzodiazepines (51), xenon (52), and
α2-adrenergic agonists (13) dose-dependently
reduce the activity of specific brain regions, includ-
ing the thalamus, cuneus-precuneus, posterior cin-
gulate cortex, and the fronto-parietal association
cortices. The obtained images are similar to those
observed during non-REM sleep, coma, generalized
seizure, and UWS (53, 54). Most of these regions
are part of the intrinsic connectivity networks DMN
and ECN (23). Ketamine is an exception, as it offers
a very different pattern of brain functional changes.
Indeed, it produces activations in the anterior cingu-
late, thalamus, putamen, and frontal cortex (55, 56).
Considering these observations, anesthesia has
obviously specific cortical effects. It could be pro-
posed that, similarly to physiological sleep, anes-
thesia-induced modifications of cortical activity
would be the result of its above-described sub-
 cortical effects. But the inverse is also possible, that
is a primary effect on the cortex, with subsequent
repercussions on cortico-sub-cortical interactions
and activity in the sub-cortical structures.
Accumulating evidence suggests that this second
hypothesis is probably the right one.
Indeed, cortical effects of anesthetic agents
occur at lower doses than sub-cortical effects (57-
59), and higher order processing cortical areas are
more sensitive than lower-order ones (60, 61). It
seems that hypnotic agents, at least those promoting
GABAergic neurotransmission, disrupt large-scale
cortical connectivity and the ability of the brain to
integrate information (62-64), while certain
 dynamic principles of the underlying networks are
maintained (65). Connectivity and anticorrelation
of DMN and ECN (66-68), and of other higher-
order networks (69), is reduced by low concentra-
tions of these agents. At those low concentrations,
connectivity is preserved or even increased in
lower-order sensory and motor networks (70), and
thalamic activation by external stimuli still
occurs (24). At concentrations producing loss of
responsiveness, connectivity of DMN and ECN
 disappears, as well as their anticorrelation. In
 contrast, DMN and ECN become anticorrelated
with thalamic activity (66), and connectivity in
lower-order sensory networks is maintained with
cross-modal interaction alterations.
CONCLUSIONS
Progress has recently been made in the under-
standing of the mechanisms of sleep and anesthe-
sia-induced alteration of consciousness, and of
 consciousness itself. Anesthesia and sleep share
common behavioral, EEG, and functional features.
However, detailed analysis reveals that they
 probably originate from different backgrounds.
Sleep is undoubtedly initiated in subcortical struc-
tures, while accumulating scientific data suggest an
initial cortical origin for anesthesia, at least during
the induction phase, with subsequent subcortical
consequences. A simple reverse sequence of events
during emergence from anesthesia is probably not
what actually happens. These hypotheses remain to
be confirmed, and verified for all classes of hypnot-
ic anesthetic agents. The link with known bio -
chemical targets also remains to be determined, as
well as the exact sequential alterations of cortico-
subcortical interactions. The currently available
functional imaging and electrophysiological
 techniques have not yielded all their secrets yet, and
further new  elements can certainly be expected in
the very near future.
References
1. Franks N. P., Zecharia A. Y., Sleep and general anesthesia,
CAN. J. ANAESTH., 58, 139-48, 2011.
2. Murphy M., Bruno M. A., Riedner B. A., Boveroux P.,
Noirhomme Q., Landsness E. C., Brichant J. F., Phillips C.,
Massimini M., Laureys S., Tononi G., Boly M., Propofol
anesthesia and sleep : a high-density EEG study, SLEEP, 34,
283-91, 2011.
3. Massimini M., Huber R., Ferrarelli F., Hill S., Tononi G.,
The sleep slow oscillation as a traveling wave, J.
NEUROSCI., 24, 6862-70, 2004.
4. Fernandez-Mendoza J., Lozano B., Seijo F., Santamarta-
Liebana E., Ramos-Platon M. J., Vela-Bueno A.,
Fernandez-Gonzalez F., Evidence of subthalamic PGO-like
waves during REM sleep in humans : a deep brain
polysomnographic study, SLEEP, 32, 1117-26, 2009.
5. Dang-Vu T. T., Schabus M., Desseilles M., Sterpenich V.,
Bonjean M., Maquet P., Functional neuroimaging insights
LINKING SLEEP AND GENERAL ANESTHESIA 169
bonhomme-:Opmaak 1  27/10/11  07:26  Pagina 169
© Acta Anæsthesiologica Belgica, 2011, 62, n° 3
170 V. BONHOMME et al.
into the physiology of human sleep, SLEEP, 33, 1589-603,
2010.
6. Leslie K., Sleigh J., Paech M. J., Voss L., Lim C. W.,
Sleigh C., Dreaming and electroencephalographic changes
during anesthesia maintained with propofol or desflurane,
ANESTHESIOLOGY, 111, 547-55, 2009.
7. Tonner P. H., Bein B., Classic electroencephalographic
parameters : median frequency, spectral edge frequency etc,
BEST PRACT. RES. CLIN. ANAESTHESIOL., 20, 147-59, 2006.
8. Wilkins L. K., Girard T. A., Cheyne J. A., Ketamine as a
primary predictor of out-of-body experiences associated
with multiple substance use, CONSCIOUS COGN., 20, 943-50,
2011.
9. Laureys S., Celesia G. G., Cohadon F., Lavrijsen J., Leon-
Carrion J., Sannita W. G., Sazbon L., Schmutzhard E., von
Wild K. R., Zeman A., Dolce G., Unresponsive wakeful-
ness syndrome : a new name for the vegetative state or
apallic syndrome, BMC MED., 8, 68, 2010.
10. Hirota K., Special cases : ketamine, nitrous oxide and
xenon, BEST PRACT. RES. CLIN. ANAESTHESIOL., 20, 69-79,
2006.
11. Hall J. E., Uhrich T. D., Barney J. A., Arain S. R.,
Ebert T. J., Sedative, amnestic, and analgesic properties of
small-dose dexmedetomidine infusions, ANESTH. ANALG.,
90, 699-705, 2000.
12. Hall J. E., Uhrich T. D., Ebert T. J., Sedative, analgesic and
cognitive effects of clonidine infusions in humans, BR. J.
ANAESTH., 86, 5-11, 2001.
13. Bonhomme V., Maquet P., Phillips C., Plenevaux A.,
Hans P., Luxen A., Lamy M., Laureys S., The effect of
clonidine infusion on distribution of regional cerebral
blood flow in volunteers, ANESTH. ANALG., 106, 899-909,
2008.
14. Solt K., Forman S. A., Correlating the clinical actions and
molecular mechanisms of general anesthetics, CURR. OPIN.
ANAESTHESIOL., 20, 300-6, 2007.
15. Franks N. P., General anaesthesia : from molecular targets
to neuronal pathways of sleep and arousal, NAT. REV.
NEUROSCI., 9, 370-86, 2008.
16. Baars B. J., Ramsoy T. Z., Laureys S., Brain, conscious
experience and the observing self, TRENDS NEUROSCI., 26,
671-5, 2003.
17. Baars B. J., Global workspace theory of consciousness :
toward a cognitive neuroscience of human experience,
PROG. BRAIN RES., 150, 45-53, 2005.
18. Tononi G., Consciousness as integrated information : a
provisional manifesto, BIOL. BULL., 215, 216-42, 2008.
19. Seeley W. W., Menon V., Schatzberg A. F., Keller J.,
Glover G. H., Kenna H., Reiss A. L., Greicius M. D.,
Dissociable intrinsic connectivity networks for salience
processing and executive control, J. NEUROSCI., 27, 2349-
56, 2007.
20. Mason M. F., Norton M. I., Van Horn J. D., Wegner D. M.,
Grafton S. T., Macrae C. N., Wandering minds : the default
network and stimulus-independent thought, SCIENCE, 315,
393-5, 2007.
21. Boly M., Phillips C., Balteau E., Schnakers C.,
Degueldre C., Moonen G., Luxen A., Peigneux P.,
Faymonville M. E., Maquet P., Laureys S., Consciousness
and cerebral baseline activity fluctuations, HUM. BRAIN
MAPP., 29, 868-74, 2008.
22. Damoiseaux J. S., Rombouts S. A., Barkhof F.,
Scheltens P., Stam C. J., Smith S. M., Beckmann C. F.,
Consistent resting-state networks across healthy subjects,
PROC. NATL. ACAD. SCI. USA, 103, 13848-53, 2006.
23. Vanhaudenhuyse A., Demertzi A., Schabus M.,
Noirhomme Q., Bredart S., Boly M., Phillips C., Soddu A.,
Luxen A., Moonen G., Laureys S., Two distinct neuronal
networks mediate the awareness of environment and of self,
J. COGN. NEUROSCI., 23, 570-8, 2011.
24. Mhuircheartaigh R. N., Rosenorn-Lanng D., Wise R.,
Jbabdi S., Rogers R., Tracey I., Cortical and subcortical
connectivity changes during decreasing levels of con-
sciousness in humans : a functional magnetic resonance
imaging study using propofol, J. NEUROSCI., 30, 9095-102,
2010.
25. Sperling R., Greve D., Dale A., Killiany R., Holmes J.,
Rosas H. D., Cocchiarella A., Firth P., Rosen B., Lake S.,
Lange N., Routledge C., Albert M., Functional MRI detec-
tion of pharmacologically induced memory impairment,
PROC. NATL. ACAD. SCI. USA, 99, 455-60, 2002.
26. Paulus M. P., Feinstein J. S., Castillo G., Simmons A. N.,
Stein M. B., Dose-dependent decrease of activation in
bilateral amygdala and insula by lorazepam during
 emotion processing, ARCH. GEN. PSYCHIATRY, 62, 282-8,
2005.
27. Coghill R. C., Talbot J. D., Evans A. C., Meyer E.,
Gjedde A., Bushnell M. C., Duncan G. H., Distributed pro-
cessing of pain and vibration by the human brain, J.
NEUROSCI., 14, 4095-108, 1994.
28. Nelson L. E., Guo T. Z., Lu J., Saper C. B., Franks N. P.,
Maze M., The sedative component of anesthesia is
 mediated by GABA(A) receptors in an endogenous sleep
pathway, NAT. NEUROSCI., 5, 979-84, 2002.
29. Samann P. G., Wehrle R., Hoehn D., Spoormaker V. I.,
Peters H., Tully C., Holsboer F., Czisch M., Development
of the Brain's Default Mode Network from Wakefulness to
Slow Wave Sleep, CEREB. CORTEX, 21, 2082-93, 2011.
30. Larson-Prior L. J., Zempel J. M., Nolan T. S., Prior F. W.,
Snyder A. Z., Raichle M. E., Cortical network functional
connectivity in the descent to sleep, PROC. NATL. ACAD. SCI.
USA, 106, 4489-94, 2009.
31. McCarley R. W., Neurobiology of REM and NREM sleep,
SLEEP MED., 8, 302-30, 2007.
32. Franks N. P., Honore E., The TREK K2P channels and their
role in general anaesthesia and neuroprotection, TRENDS
PHARMACOL. SCI., 25, 601-8, 2004.
33. Kotani Y., Shimazawa M., Yoshimura S., Iwama T.,
Hara H., The experimental and clinical pharmacology of
propofol, an anesthetic agent with neuroprotective proper-
ties, CNS NEUROSCI. THER., 14, 95-106, 2008.
34. Meuret P., Backman S. B., Bonhomme V., Plourde G.,
Fiset P., Physostigmine reverses propofol-induced uncon-
sciousness and attenuation of the auditory steady state
response and bispectral index in human volunteers,
ANESTHESIOLOGY, 93, 708-17, 2000.
35. Lewis A. S., Chetkovich D. M., HCN channels in behavior
and neurological disease : too hyper or not active
enough ?, MOL. CELL. NEUROSCI., 46, 357-67, 2011.
36. Shiraishi M., Harris R. A., Effects of alcohols and
 anesthetics on recombinant voltage-gated Na+ channels,
J. PHARMACOL. EXP. THER., 309, 987-94, 2004.
37. Zecharia A. Y., Franks N. P., General anesthesia and
ascending arousal pathways, ANESTHESIOLOGY, 111, 695-6,
2009.
38. Mantz J., Hemmings H. C. Jr., Sleep and anesthesia : the
histamine connection, ANESTHESIOLOGY, 115, 8-9, 2011.
39. Lee U., Muller M., Noh G. J., Choi B., Mashour G. A.,
Dissociable network properties of anesthetic state transi-
tions, ANESTHESIOLOGY, 114, 872-81, 2011.
40. Zecharia A. Y., Nelson L. E., Gent T. C., Schumacher M.,
Jurd R., Rudolph U., Brickley S. G., Maze M.,
Franks N. P., The involvement of hypothalamic sleep path-
ways in general anesthesia : testing the hypothesis using
the GABAA receptor beta3N265M knock-in mouse,
J. NEUROSCI., 29, 2177-87, 2009.
41. Luo T., Leung L. S., Basal forebrain histaminergic trans-
mission modulates electroencephalographic activity and
emergence from isoflurane anesthesia, ANESTHESIOLOGY,
111, 725-33, 2009.
bonhomme-:Opmaak 1  27/10/11  07:26  Pagina 170
© Acta Anæsthesiologica Belgica, 2011, 62, n° 3
42. Luo T., Leung L. S., Involvement of tuberomamillary
 histaminergic neurons in isoflurane anesthesia,
ANESTHESIOLOGY, 115, 36-43, 2011.
43. Plourde G., Chartrand D., Fiset P., Font S., Backman S. B.,
Antagonism of sevoflurane anaesthesia by physostigmine :
effects on the auditory steady-state response and bispectral
index, BR. J. ANAESTH., 91, 583-6, 2003.
44. Xie G., Deschamps A., Backman S. B., Fiset P.,
Chartrand D., Dagher A., Plourde G., Critical involvement
of the thalamus and precuneus during restoration of con-
sciousness with physostigmine in humans during propofol
anaesthesia : a positron emission tomography study, BR. J.
ANAESTH., 106, 548-57, 2011.
45. Nelson L. E., Lu J., Guo T., Saper C. B., Franks N. P.,
Maze M., The alpha2-adrenoceptor agonist dexmedetomi-
dine converges on an endogenous sleep-promoting pathway
to exert its sedative effects, ANESTHESIOLOGY, 98, 428-36,
2003.
46. Bonhomme V., Boveroux P., Hans P., Brichant J. F.,
Vanhaudenhuyse A., Boly M., Laureys S., Influence of
anesthesia on cerebral blood flow, cerebral metabolic rate,
and brain functional connectivity, CURR. OPIN.
ANAESTHESIOL., 24, 474-9, 2011.
47. Fiset P., Paus T., Daloze T., Plourde G., Meuret P.,
Bonhomme V., Hajj-Ali N., Backman S. B., Evans A. C.,
Brain mechanisms of propofol-induced loss of conscious-
ness in humans : a positron emission tomographic study, J.
NEUROSCI., 19, 5506-13, 1999.
48. Kaisti K. K., Metsahonkala L., Teras M., Oikonen V.,
Aalto S., Jaaskelainen S., Hinkka S., Scheinin H., Effects of
surgical levels of propofol and sevoflurane anesthesia on
cerebral blood flow in healthy subjects studied with
positron emission tomography, ANESTHESIOLOGY, 96, 1358-
70, 2002.
49. Kaisti K. K., Langsjo J. W., Aalto S., Oikonen V., Sipila H.,
Teras M., Hinkka S., Metsahonkala L., Scheinin H., Effects
of sevoflurane, propofol, and adjunct nitrous oxide on
regional cerebral blood flow, oxygen consumption, and
blood volume in humans, ANESTHESIOLOGY, 99, 603-13,
2003.
50. Veselis R. A., Feshchenko V. A., Reinsel R. A.,
Dnistrian A. M., Beattie B., Akhurst T. J., Thiopental and
propofol affect different regions of the brain at similar
pharmacologic effects, ANESTH. ANALG., 99, 399-408, table,
2004.
51. Veselis R. A., Reinsel R. A., Beattie B. J., Mawlawi O. R.,
Feshchenko V. A., DiResta G. R., Larson S. M.,
Blasberg R. G., Midazolam changes cerebral blood flow in
discrete brain regions : an H2(15)O positron emission
tomography study, ANESTHESIOLOGY, 87, 1106-17, 1997.
52. Rex S., Schaefer W., Meyer P. H., Rossaint R., Boy C.,
Setani K., Bull U., Baumert J. H., Positron emission tomo -
graphy study of regional cerebral metabolism during
 general anesthesia with xenon in humans, ANESTHESIOLOGY,
105, 936-43, 2006.
53. Boveroux P., Bonhomme V., Boly M., Vanhaudenhuyse A.,
Maquet P., Laureys S., Brain function in physiologically,
pharmacologically, and pathologically altered states of
consciousness, INT. ANESTHESIOL. CLIN., 46, 131-46, 2008.
54. Vanhaudenhuyse A., Noirhomme Q., Tshibanda L. J.,
Bruno MA., Boveroux P., Schnakers C., Soddu A.,
Perlbarg V., Ledoux D., Brichant J. F., Moonen G.,
Maquet P., Greicius M. D., Laureys S., Boly M., Default
network connectivity reflects the level of consciousness in
non-communicative brain-damaged patients, BRAIN, 133,
161-71, 2010.
55. Langsjo J. W., Kaisti K. K., Aalto S., Hinkka S., Aantaa R.,
Oikonen V., Sipila H., Kurki T., Silvanto M., Scheinin H.,
Effects of subanesthetic doses of ketamine on regional
 cerebral blood flow, oxygen consumption, and blood
 volume in humans, ANESTHESIOLOGY, 99, 614-23, 2003.
56. Langsjo J. W., Salmi E., Kaisti KK., Aalto S., Hinkka S.,
Aantaa R., Oikonen V., Viljanen T., Kurki T., Silvanto M.,
Scheinin H., Effects of subanesthetic ketamine on regional
cerebral glucose metabolism in humans, ANESTHESIOLOGY,
100, 1065-71, 2004.
57. Velly L. J., Rey M. F., Bruder N. J., Gouvitsos F. A.,
Witjas T., Regis J. M., Peragut J. C., Gouin F. M.,
Differential dynamic of action on cortical and subcortical
structures of anesthetic agents during induction of anesthe-
sia, ANESTHESIOLOGY, 107, 202-12, 2007.
58. Bonhomme V., Fiset P., Meuret P., Backman S., Plourde G.,
Paus T., Bushnell M. C., Evans AC., Propofol anesthesia
and cerebral blood flow changes elicited by vibrotactile
stimulation : a positron emission tomography study, J.
NEUROPHYSIOL., 85, 1299-308, 2001.
59. Heinke W., Koelsch S., The effects of anesthetics on brain
activity and cognitive function, CURR. OPIN. ANAESTHESIOL.,
18, 625-31, 2005.
60. Dueck M. H., Petzke F., Gerbershagen H. J., Paul M.,
Hesselmann V., Girnus R., Krug B., Sorger B., Goebel R.,
Lehrke R., Sturm V., Boerner U., Propofol attenuates
responses of the auditory cortex to acoustic stimulation in
a dose-dependent manner : a FMRI study, ACTA ANAESTHE -
SIOL. SCAND., 49, 784-91, 2005.
61. Ramani R., Qiu M., Constable R. T., Sevoflurane 0.25
MAC preferentially affects higher order association areas :
a functional magnetic resonance imaging study in volun-
teers, ANESTH. ANALG., 105, 648-55, 2007.
62. Lee U., Kim S., Noh G. J., Choi B. M., Hwang E.,
Mashour G. A., The directionality and functional organiza-
tion of frontoparietal connectivity during consciousness
and anesthesia in humans, CONSCIOUS. COGN., 18, 1069-78,
2009.
63. Lee U., Mashour G. A., Kim S., Noh G. J., Choi B. M.,
Propofol induction reduces the capacity for neural
 information integration : implications for the mechanism of
consciousness and general anesthesia, CONSCIOUS. COGN.,
18, 56-64, 2009.
64. Alkire M. T., Loss of effective connectivity during general
anesthesia, INT. ANESTHESIOL. CLIN., 46, 55-73, 2008.
65. Lee U., Oh G., Kim S., Noh G., Choi B., Mashour G. A.,
Brain networks maintain a scale-free organization across
consciousness, anesthesia, and recovery : evidence for
adaptive reconfiguration, ANESTHESIOLOGY, 113, 1081-91,
2010.
66. Boveroux P., Vanhaudenhuyse A., Bruno M. A.,
Noirhomme Q., Lauwick S., Luxen A., Degueldre C.,
Plenevaux A., Schnakers C., Phillips C., Brichant J. F.,
Bonhomme V., Maquet P., Greicius M. D., Laureys S.,
Boly M., Breakdown of within- and between-network
 resting state functional magnetic resonance imaging con-
nectivity during propofol-induced loss of consciousness,
ANESTHESIOLOGY, 113, 1038-53, 2010.
67. Martuzzi R., Ramani R., Qiu M., Rajeevan N., Constable R.
T., Functional connectivity and alterations in baseline brain
state in humans, NEUROIMAGE, 49, 823-34, 2010.
68. Stamatakis E. A., Adapa R. M., Absalom A. R.,
Menon D. K., Changes in Resting Neural Connectivity dur-
ing Propofol Sedation, PLOS ONE, 5, e14224, 2010.
69. Alkire M. T., Gruver R., Miller J., McReynolds J. R.,
Hahn E. L., Cahill L., Neuroimaging analysis of an anes-
thetic gas that blocks human emotional memory, PROC.
NATL. ACAD. SCI. USA, 105, 1722-7, 2008.
70. Greicius M. D., Kiviniemi V., Tervonen O., Vainionpaa V.,
Alahuhta S., Reiss A. L., Menon V., Persistent default-
mode network connectivity during light sedation, HUM.
BRAIN MAPP., 29, 839-47, 2008.
LINKING SLEEP AND GENERAL ANESTHESIA 171
bonhomme-:Opmaak 1  27/10/11  07:26  Pagina 171
bonhomme-:Opmaak 1  27/10/11  07:26  Pagina 172
